Rapid assays of SARS-CoV-2 virus and noble biosensors by nanomaterials

Y Liu, Y Li, Y Hang, L Wang, J Wang, N Bao, Y Kim… - Nano …, 2024 - Springer
The COVID-19 outbreak caused by SARS-CoV-2 in late 2019 has spread rapidly across the
world to form a global epidemic of respiratory infectious diseases. Increased investigations …

Research progress of biosensors for detection of SARS-CoV-2 variants based on ACE2

H Wei, C Zhang, X Du, Z Zhang - Talanta, 2023 - Elsevier
Currently, the coronavirus disease 2019 (COVID-19) pandemic is ravaging the world,
causing serious crisis in economy and human health. The top priority is the detection and …

[HTML][HTML] Virus variant–specific clinical performance of SARS coronavirus two rapid antigen tests in point-of-care use, from November 2020 to January 2022

I Wagenhäuser, K Knies, D Hofmann… - Clinical Microbiology …, 2023 - Elsevier
Objectives Antigen rapid diagnostic tests (RDTs) for SARS coronavirus 2 (SARS-CoV-2) are
quick, widely available, and inexpensive. Consequently, RDTs have been established as an …

An update on detection technologies for SARS-CoV-2 variants of concern

W Jiang, W Ji, Y Zhang, Y **e, S Chen, Y **, G Duan - Viruses, 2022 - mdpi.com
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is responsible for the
global epidemic of Coronavirus Disease 2019 (COVID-19), with a significant impact on the …

PdPtRu trimetallic nanozymes and application to electrochemical immunosensor for sensitive SARS-COV-2 antigen detection

Y Li, J Xue, R Yu, S Chen, X Deng, A Chen, J Qiu - Talanta, 2023 - Elsevier
Herein, a ternary PdPtRu nanodendrite as novel trimetallic nanozyme was reported, which
possessed excellent peroxidase-like activity as well as electro-catalytic activity on account of …

Clinical performance of rapid and point-of-care antigen tests for SARS-CoV-2 variants of concern: a living systematic review and meta-analysis

J Kim, H Sung, H Lee, JS Kim, S Shin, S Jeong, M Choi… - Viruses, 2022 - mdpi.com
Rapid antigen tests (RATs) for detecting severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) are widely used in the Coronavirus disease 2019 (COVID-19) pandemic …

[HTML][HTML] Rapid antigen tests for SARS-CoV-2—a synopsis of the medical evidence

C Wertenauer, C Pfeifer, M Roskos, W März - Diagnostic Microbiology and …, 2023 - Elsevier
ABSTRACT SARS-CoV-2, the causative agent of the COVID-19 pandemic, continues to
influence health, economy, and stability worldwide. Diagnostic testing for SARS-CoV-2 is …

Performance and application evaluation of SARS‐CoV‐2 antigen assay

Q Ye, W Shao, H Meng - Journal of Medical Virology, 2022 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) nucleic acid detection is
the gold standard for the laboratory diagnosis of coronavirus disease 2019 (COVID‐19) …

Diagnostic accuracy of the Panbio COVID-19 antigen rapid test device for SARS-CoV-2 detection in Kenya, 2021: A field evaluation

JK Irungu, P Munyua, C Ochieng, B Juma, P Amoth… - PLoS …, 2023 - journals.plos.org
Background Accurate and timely diagnosis is essential in limiting the spread of SARS-CoV-2
infection. The reference standard, rRT-PCR, requires specialized laboratories, costly …

Epidemiological characteristics of Omicron and Delta SARS-CoV-2 variant infection in Santiago, Chile

A Mella-Torres, A Escobar, C Barrera-Avalos… - Frontiers in public …, 2022 - frontiersin.org
The variant of concern (VOC) SARS-CoV-2 Omicron (B. 1.1529) has been described as a
highly contagious variant but less virulent than the current variant being monitored (VBM) …